| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 886,2 k € | +0.2% | 884,6 k € | -0.0% | 884,9 k € | -1.0% | 894,1 k € | -1.3% | 906,3 k € | +6.1% | 853,8 k € | +92.3% | 444,0 k € | |
| EBITDA | 885,1 k € | +0.1% | 884,4 k € | -0.0% | 884,7 k € | -1.5% | 898,3 k € | -0.6% | 903,6 k € | +6.0% | 852,2 k € | +217.6% | 268,3 k € | |
| Operating profit | 364,5 k € | +0.4% | 363,2 k € | -0.3% | 364,2 k € | -2.4% | 373,1 k € | -1.3% | 378,0 k € | +18.5% | 319,1 k € | +563.7% | -68,8 k € | |
| Profit/loss | 307,9 k € | +0.9% | 305,1 k € | +29.3% | 236,0 k € | +583.4% | -48,8 k € | +54.5% | -107,2 k € | +17.1% | -129,4 k € | +63.8% | -357,7 k € | |
| Equity | 1,5 M € | +25.1% | 1,2 M € | +33.1% | 921,0 k € | +34.5% | 685,0 k € | -6.7% | 733,8 k € | -12.8% | 841,0 k € | +426.4% | -257,7 k € | |
| Total assets | 1,9 M € | +19.8% | 1,6 M € | -24.2% | 2,1 M € | -37.9% | 3,4 M € | -53.9% | 7,4 M € | +4.0% | 7,1 M € | +63.6% | 4,4 M € | |
| Cash | 14,7 k € | +231.9% | 4,4 k € | -92.1% | 56,1 k € | -93.2% | 829,3 k € | +1580.5% | 49,4 k € | -22.0% | 63,3 k € | +134.3% | 27,0 k € | |
| Debts | 197,0 k € | +0.5% | 196,1 k € | -81.7% | 1,1 M € | -60.7% | 2,7 M € | -58.3% | 6,5 M € | +6.2% | 6,2 M € | +33.7% | 4,6 M € | |
| Staff | — | — | — | — | — | — | 3,3 | |||||||
Public limited company · Gent · incorporated on 16/12/2016
Public limited company profitable and well capitalised. Cash position rising (+231.9%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
MD Pharma is a Public limited company incorporated in 2016. Its main activity is: Leasing of intellectual property and similar products, except copyrighted works. Its registered office is in Gent.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette